Market revenue in 2023 | USD 677.4 million |
Market revenue in 2030 | USD 943.5 million |
Growth rate | 4.8% (CAGR from 2023 to 2030) |
Largest segment | Liquid delivery device |
Fastest growing segment | Powder delivery device |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Powder delivery device, Liquid Delivery Device, Pressurized Metered Dose Inhaler |
Key market players worldwide | GSK PLC ADR, Teva Pharmaceutical Industries Ltd, AptarGroup Inc, UCB SA, Teleflex Inc, 3M Co, OptiNose Inc, Bespak, Intersect ENT |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to intranasal drug and vaccine delivery market will help companies and investors design strategic landscapes.
Liquid delivery device was the largest segment with a revenue share of 43.27% in 2023. Horizon Databook has segmented the Argentina intranasal drug and vaccine delivery market based on powder delivery device, liquid delivery device, pressurized metered dose inhaler covering the revenue growth of each sub-segment from 2018 to 2030.
Healthcare spending in Argentina represents around 7.0% of its total GDP. Around 70.0% to 75.0% of medical products in Argentina are imported. Argentina primarily imports medical devices from the U.S. and is one of the key markets for the U.S. in Latin America.
The U.S. is one of Argentina's noteworthy exporters and is positioned among the best three source nations in the FDI. Furthermore, unavailability or limited availability of resources in Argentina has also restricted many major market players to from entering the market.
Growing preference for cost-effective generics and unfavorable reimbursement scenario may limit the adoption for intranasal drug and vaccine delivery devices. However, the emergence of local players may have a positive impact on the market.
Horizon Databook provides a detailed overview of country-level data and insights on the Argentina intranasal drug and vaccine delivery market , including forecasts for subscribers. This country databook contains high-level insights into Argentina intranasal drug and vaccine delivery market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account